Cite

HARVARD Citation

    Caneparo, V. et al. (n.d.). Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy. Inflammatory bowel diseases. 22 (12), p. . [Online]. 
  
Back to record